🎯
LATEST VERIFIED AI EXECUTION
Our quantitative model captured a massive +11.41% net profit on $TIP.MI in just 121h 17m. Stop guessing, start executing.

$BIVI
BioVie Inc.
FREE PREVIEW
AVG HISTORICAL GAP-2.13%
MAX GAP RECORD-9.44%
PREMIUM
AI ACCURACY RATE92.4%
Unlock AI Insights 🔓LAST 10 EARNINGS GAPS (%)
QUANTITATIVE LIVE RADAR BLOTTER
Institutional execution stream for $BIVI
EXECUTIONS2 LOGS
WIN RATE••.•%
NET ROI+•••.••%
| Execution Date | Strategy & Setup | Direction | Execution Range | Hold Time | Exit Trigger | Net PnL |
|---|---|---|---|---|---|---|
| 2026-08-27 | QUANT ALGO | SELL x5 | $•••.•• → $•••.•• | 6m | 🔒 ENCRYPTED | -13.29% |
| ••••-••-•• | 🔒 LOCKED | ••• x• | $•••.•• → $•••.•• | ••h ••m | 🔒 LOCKED | +••.••% |
🔒 Institutional Data Protected
UNLOCK FULL BLOTTERExact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.
VOLATILITY & BIAS PROFILE
AVG VOLATILITY3.2%
Bullish Gaps
Bearish Gaps
Neutral
Intelligence Brief
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild… Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL